Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 28, 2025 09:57 ET | Source: Trethera Corporation

Trethera Successfully Completes Phase 1 Dose Escalation Trial Demonstrating Broad Therapeutic Window, Favorable Safety, and Confirmed Target Engagement

Achieved complete target inhibition, durable tumor control, and a 36-fold dose range without dose-limiting toxicity— advancing toward combination trials.
October 16, 2025 08:00 ET | Source: Profound Medical Corp.

Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone

TORONTO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
October 14, 2025 08:30 ET | Source: Profound Medical Corp.

Profound Medical to Participate in the Stifel 2025 Healthcare Conference

TORONTO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
October 07, 2025 07:45 ET | Source: Profound Medical Corp.

Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter

TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
September 10, 2025 10:11 ET | Source: Trethera Corporation

Trethera Successfully Completes Enrollment of Phase 1 Dose Escalation Trial for Patients with Solid Tumors

Phase 1 enrollment of TRE-515 in solid tumors completed; 36-fold dose escalation well tolerated, with early signs of antitumor activity and durable benefit
August 29, 2025 10:02 ET | Source: Urology Care Foundation

PROstate of Mind: The Mindset That Could Save Your Life This September

BALTIMORE, Aug. 29, 2025 (GLOBE NEWSWIRE) -- September is Prostate Cancer Awareness Month, and the Urology Care Foundation (UCF), the official foundation of the American Urological Association...
August 28, 2025 08:00 ET | Source: Profound Medical Corp.

Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference

TORONTO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
August 26, 2025 10:22 ET | Source: Trethera Corporation

Trethera Awarded $2.3 Million NIH Grant to Study TRE-515 Combined with Radiation Therapy in Prostate Cancer Preclinical Models

Fresh NIH funding follows FDA Fast Track designation, reinforcing confidence in TRE-515 potential to advance prostate cancer treatment.
June 10, 2025 08:00 ET | Source: Profound Medical Corp.

Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction

TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...
June 04, 2025 07:45 ET | Source: Profound Medical Corp.

Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®

TORONTO, June 04, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets...